Terms: = Gastric cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH AND Treatment
87 results:
1. Efficacy and safety of neoadjuvant sintilimab in combination with FLOT chemotherapy in patients with HER2-negative locally advanced gastric or gastroesophageal junction adenocarcinoma: an investigator-initiated, single-arm, open-label, phase II study.
Li N; Li Z; Fu Q; Zhang B; Zhang J; Wan XB; Lu CM; Wang JB; Deng WY; Ma YJ; Bie LY; Wang MY; Li J; Xia QX; Wei C; Luo SX
Int J Surg; 2024 Apr; 110(4):2071-2084. PubMed ID: 38320099
[TBL] [Abstract] [Full Text] [Related]
2. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study.
Shitara K; Rha SY; Wyrwicz LS; Oshima T; Karaseva N; Osipov M; Yasui H; Yabusaki H; Afanasyev S; Park YK; Al-Batran SE; Yoshikawa T; Yanez P; Dib Bartolomeo M; Lonardi S; Tabernero J; Van Cutsem E; Janjigian YY; Oh DY; Xu J; Fang X; Shih CS; Bhagia P; Bang YJ;
Lancet Oncol; 2024 Feb; 25(2):212-224. PubMed ID: 38134948
[TBL] [Abstract] [Full Text] [Related]
3. Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer.
Nishikawa K; Kawakami H; Shimokawa T; Fujitani K; Tamura S; Endo S; Kobayashi M; Kawada J; Kurokawa Y; Tsuburaya A; Yoshikawa T; Sakamoto J; Satoh T;
Int J Clin Oncol; 2023 Nov; 28(11):1501-1510. PubMed ID: 37634209
[TBL] [Abstract] [Full Text] [Related]
4. Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study.
Kawabata R; Chin K; Takahari D; Hosaka H; Muto O; Shindo Y; Nagata N; Yabusaki H; Imamura H; Endo S; Kashiwada T; Nakamura M; Hihara J; Kobayashi M; Sagawa T; Saito S; Sato A; Yamada T; Okano N; Shimada K; Matsushima M; Kataoka M; Matsumoto S; Goto M; Kotaka M; Shiraishi T; Yamai H; Nagashima F; Ishizuka N; Yamaguchi K
Gastric Cancer; 2023 Nov; 26(6):1020-1029. PubMed ID: 37610558
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
6. Using Normalized Carcinoembryonic Antigen and Carbohydrate Antigen 19 to Predict and Monitor the Efficacy of Neoadjuvant Chemotherapy in Locally Advanced gastric cancer.
Tang XH; Wu XL; Gan XJ; Wang YD; Jia FZ; Wang YX; Zhang Y; Gao XY; Li ZY
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569566
[TBL] [Abstract] [Full Text] [Related]
7. The clinical impacts of postoperative complications after colon cancer surgery for the clinical course of adjuvant treatment and survival.
Aoyama T; Oba K; Honda M; Muto M; Mayanagi S; Maeda H; Kanda M; Kashiwabara K; Sakamoto J; Yoshikawa T
Int J Clin Oncol; 2023 Jun; 28(6):777-784. PubMed ID: 37039949
[TBL] [Abstract] [Full Text] [Related]
8. The Impact of Nutritional Support on Survival Outcomes in Patients with Advanced gastric Adenocarcinoma Treated with Chemotherapy.
Sugiyama K; Shiraishi K; Motohashi T; Onoda S; Sato M; Kato K; Uda H; Hattori M; Suenaga M; Hirashima N; Shimada M; Kataoka M; Kitagawa C
Nutr Cancer; 2023; 75(3):867-875. PubMed ID: 36591915
[TBL] [Abstract] [Full Text] [Related]
9. Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.
Rosery V; Mika S; Schmid KW; Reis H; Stuschke M; Treckmann J; Markus P; Schumacher B; Albers D; Mende B; Lahner H; Wiesweg M; Schuler M; Siveke JT; Kasper S
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4315-4325. PubMed ID: 36071236
[TBL] [Abstract] [Full Text] [Related]
10. Association Between Peripheral Neuropathy Induced by Oxaliplatin at First-line Chemotherapy and Efficacy of Paclitaxel at Second-line Chemotherapy in Patients With Advanced gastric cancer.
Fujii H; Sadaka S; Ajisawa K; Okumura N; Makiyama A; Iihara H; Yasufuku I; Ohata K; Kobayashi R; Tanaka Y; Hayashi H; Suzuki A
Anticancer Res; 2022 Sep; 42(9):4581-4588. PubMed ID: 36039452
[TBL] [Abstract] [Full Text] [Related]
11. Efficacy Evaluation of 64-Slice Spiral Computed Tomography Images in Laparoscopic-Assisted Distal Gastrectomy for gastric cancer under the Reconstruction Algorithm.
Yu W; Li X; Zhou H; Zhang Y; Sun Z
Contrast Media Mol Imaging; 2022; 2022():2464640. PubMed ID: 36017021
[TBL] [Abstract] [Full Text] [Related]
12. Real-world effectiveness of third- or later-line treatment in Japanese patients with HER2-positive, unresectable, recurrent or metastatic gastric cancer: a retrospective observational study.
Sakai D; Omori T; Fumita S; Fujita J; Kawabata R; Matsuyama J; Yasui H; Hirao M; Kawase T; Kishi K; Taniguchi Y; Miyazaki Y; Kawada J; Satake H; Miura T; Miyake A; Kurokawa Y; Yamasaki M; Yamada T; Satoh T; Eguchi H; Doki Y
Int J Clin Oncol; 2022 Jul; 27(7):1154-1163. PubMed ID: 35489010
[TBL] [Abstract] [Full Text] [Related]
13. [A Case of Long-Term Progress Control of Unresectable Progressive gastric cancer with Nivolumab Introduced during Effective Duration of Secondary treatment].
Eguchi S; Akamaru Y; Wada N; Shimaoka T; Harada S; Ikeshima R; Munakata K; Takiuchi D; Hama N; Ota H; Shibata K
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2045-2047. PubMed ID: 35045488
[TBL] [Abstract] [Full Text] [Related]
14. The association between effectiveness of first-line treatment and second-line treatment in gastro-oesophageal cancer.
van Velzen MJM; Pape M; Dijksterhuis WPM; Slingerland M; van Voorthuizen T; Beerepoot LV; Creemers GJ; Derks S; Mohammad NH; Verhoeven RHA; van Laarhoven HWM
Eur J Cancer; 2021 Oct; 156():60-69. PubMed ID: 34425405
[TBL] [Abstract] [Full Text] [Related]
15. The Discordance of Clinical and Pathologic Staging in Locally Advanced gastric Adenocarcinoma.
Papageorge MV; de Geus SWL; Zheng J; Woods AP; Ng SC; Cassidy MR; McAneny D; Tseng JF; Sachs TE
J Gastrointest Surg; 2021 Jun; 25(6):1363-1369. PubMed ID: 33846934
[TBL] [Abstract] [Full Text] [Related]
16. cancer Cachexia Reduces the Efficacy of Nivolumab treatment in Patients With Advanced gastric cancer.
Fujii H; Makiyama A; Iihara H; Okumura N; Yamamoto S; Imai T; Arakawa S; Kobayashi R; Tanaka Y; Yoshida K; Suzuki A
Anticancer Res; 2020 Dec; 40(12):7067-7075. PubMed ID: 33288604
[TBL] [Abstract] [Full Text] [Related]
17. Impact of HER2 expression on EGFR-TKI treatment outcomes in lung tumors harboring EGFR mutations: A HER2-CS study subset analysis.
Ohashi K; Ninomiya K; Yoshioka H; Bessho A; Shibayama T; Aoe K; Ishikawa N; Kozuki T; Kawai H; Kuyama S; Miyoshi S; Fujitaka K; Obata H; Tsubata Y; Awaya Y; Inoue M; Inoue K; Horita N; Yanai H; Hotta K; Kiura K
Lung Cancer; 2020 Dec; 150():83-89. PubMed ID: 33096420
[TBL] [Abstract] [Full Text] [Related]
18. [Efficacy of Amrubicin Monotherapy for Patients with Extrapulmonary Neuroendocrine Carcinomas Refractory to Platinum-Based Chemotherapy].
Funasaka C; Kanemasa Y; Kageyama A; Shimoyama T; Omuro Y
Gan To Kagaku Ryoho; 2020 Aug; 47(8):1205-1208. PubMed ID: 32829355
[TBL] [Abstract] [Full Text] [Related]
19. An ALK-positive lung adenocarcinoma with gastric and skin metastasis: a case report and literature review.
Duan X; Zhao X; Wang S
Ann Palliat Med; 2021 May; 10(5):5797-5807. PubMed ID: 32819126
[TBL] [Abstract] [Full Text] [Related]
20. Health-related quality of life and health utility score of patients with gastric cancer: A multi-centre cross-sectional survey in China.
Xia R; Zeng H; Liu Q; Liu S; Zhang Z; Liu Y; Guo G; Song G; Zhu Y; Wu X; Song B; Liao X; Chen Y; Wei W; Chen G; Chen W; Zhuang G
Eur J Cancer Care (Engl); 2020 Nov; 29(6):e13283. PubMed ID: 32602238
[TBL] [Abstract] [Full Text] [Related]
[Next]
